Salvatore Emma Jr., CEO/President/Director at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT), bought 21,110 shares at $6.50 ($137K) on 2015-06-15, disclosed to the SEC on 2015-12-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| HRT | BUY | 2015-06-16 | $7K | — | Filing → |
| HRT | SELL | 2014-08-20 | $94K | — | Filing → |